Additional Pipeline Programs


Our research scientists possess the skills and experience necessary to bring compounds from basic research concepts to drug candidate stage.

The Company has a rich and diversified pipeline with compounds in all phases of clinical development.

Our research and development focus is on addressing diseases and disorders of the central nervous and endocrine systems, which include therapeutic categories ranging from diabetes to stress-related disorders and neurodegenerative diseases. Central nervous system and endocrinology drug therapies are among the largest therapeutic categories, accounting for over $150 billion in worldwide drug sales according to Global Data (2014).